Home > LSE Health and Social Care > Outputs > Eurohealth > Eurohealth Volume 14 Number 4

Eurohealth Volume 14 Number 4


Perspectives from the Commission

1. Research and innovation in pharmaceuticals: covering unmet needs 

Androulla Vassiliou

3. Does fostering pharmaceutical innovation and competitiveness benefit the European patient? 

Georgette Lalis

European snapshots

7. Changing regional health governance in France

Zeynep Or

8. Regionalisation reversal in Canada 

Gregory P Marchildon

10. Czech Republic: first steps on the path to health care reform 

Lucia Kossarova and Henrieta Maďarová

12. The Finnish welfare state meets the consumer society 

Hannu Valtonen

Mental Health Reform

14. New and old challenges in the reform of mental health systems in Spain 

Joan Costa-Font, Juan Cabases Hita, Jordi Alonso, Luis Salvador-Carulla and David McDaid

18. Liberalisation of health care in the Netherlands: the case of mental health care 

Frank van Hoof, Ineke Kok and Joost Vijselaar

Health Policy Development

22. Devolution and health policy in the UK 

Scott L Greer

25. Engagement with Russia - not isolation - in the health sector 

Edward J Burger and E Wayne Merry

29. Health care and pharmaceutical policies in Turkey after 2003 

Nebibe Varol and Omer Saka

Evidence-informed Decision Making

33. "Mythbuster" Generic drugs are lower quality and less safe than brand name drugs

35 "Bandolier" Gout and drinking